Evaluation of the Effect of Radiotherapy Timing on Toxicity in HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine During the Adjuvant Period

Evaluation of the Effect of Radiotherapy Timing on Toxicity in HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine During the Adjuvant Period

Aim: Breast cancer is the second leading cause of cancer-related deaths in women. Approximately 20-25% of breast cancers express HER2 and are associated with poor prognosis. With the use of HER2-targeted therapies, there has been an increase in treatment success for breast cancer cells overexpressin...

Full description

Saved in:
Bibliographic Details
Main Authors: İlknur Deliktaş Onur, Oğuzcan Kınıkoğlu, Gözde Kavgacı, Ömer Faruk Kuzu, Tuğba Başoğlu, Öztürk Ateş, Cengiz Karaçin
Format: Article
Language:English
Published: Galenos Publishing House 2025-04-01
Series:Acta Haematologica Oncologica Turcica
Subjects:
antibody-drug conjugates
adjuvant t-dm1
trastuzumab extensive
her2-positive breast cancer
Online Access:https://actaoncologicaturcica.com/articles/evaluation-of-the-effect-of-radiotherapy-timing-on-toxicity-in-her2-positive-breast-cancer-receiving-trastuzumab-emtansine-during-the-adjuvant-period/doi/ahot.galenos.2024.15921
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://actaoncologicaturcica.com/articles/evaluation-of-the-effect-of-radiotherapy-timing-on-toxicity-in-her2-positive-breast-cancer-receiving-trastuzumab-emtansine-during-the-adjuvant-period/doi/ahot.galenos.2024.15921

Similar Items